Trial Summary
What is the purpose of this trial?
This is an observational study to address the important knowledge gap of the metabolic and inflammatory impact of acute overeating and whether timing of acute overeating may modify these effects. The hypothesis is that acute overconsumption of calories will promote inflammation and metabolic dysfunction, with the most detrimental effects observed with evening caloric overconsumption. The expectation is that this study to provide critical insights into the biological consequences of overeating, which will direct novel approaches combating overeating and its detrimental health effects.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment involving meal timing for metabolic health?
Research suggests that meal timing can influence metabolic health, with studies indicating that eating earlier in the day and increasing fasting periods between meals may help with weight control and improve metabolic health. Additionally, consuming more calories in the evening is linked to higher chances of obesity and metabolic syndrome.12345
Is meal timing generally safe for humans?
How does meal timing differ from other treatments for metabolic health?
Meal timing is unique because it focuses on when you eat rather than what you eat, which can influence your body's metabolism and help manage weight and metabolic health. Unlike traditional treatments that may focus on diet composition or medication, this approach emphasizes the timing of meals to potentially improve health outcomes.234510
Research Team
Lisa Chow, MD
Principal Investigator
University of Minnesota
Eligibility Criteria
This trial is for individuals aged 18-30 with a normal BMI (18.5 - 24.9 kg/m2) and a weight of at least 120 lbs. Participants should not be pregnant or have any comorbid conditions.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Observation
Participants are observed for metabolic and inflammatory effects of acute overeating
Follow-up
Participants are monitored for safety and effectiveness after observation
Treatment Details
Interventions
- Meals (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor
Shashank Priya
University of Minnesota
Chief Executive Officer since 2023
PhD in Materials Engineering from Penn State
Charles Semba
University of Minnesota
Chief Medical Officer since 2021
MD from the University of Minnesota Medical School